Sorbara, Matthew T.
Pamer, Eric G. http://orcid.org/0000-0002-6755-9904
Article History
Accepted: 19 November 2021
First Online: 6 January 2022
Competing interests
: E.G.P. serves on the advisory board of Diversigen, has received speaker honoraria from Bristol Myers Squibb, Celgene, Seres Therapeutics, MedImmune, Novartis and Ferring Pharmaceuticals, is an inventor on patent applications WPO2015179437A1, entitled “Methods and compositions for reducing <i>Clostridium difficile</i> infection”, and WO2017091753A1, entitled “Methods and compositions for reducing vancomycin-resistant enterococci infection or colonization”, and holds patents that receive royalties from Seres Therapeutics Inc. M.T.S. declares no competing interests.